• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

点击化学在PROTACs研发中的应用

Click chemistry in the development of PROTACs.

作者信息

Yang Ce, Tripathi Ravi, Wang Binghe

机构信息

Department of Chemistry and Center for Diagnostics and Therapeutics, Georgia State University Atlanta Georgia 30303 USA

出版信息

RSC Chem Biol. 2023 Dec 29;5(3):189-197. doi: 10.1039/d3cb00199g. eCollection 2024 Mar 6.

DOI:10.1039/d3cb00199g
PMID:38456041
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10915971/
Abstract

Proteolysis-targeting chimeras or PROTACs are hetero-bifunctional molecules designed to mediate the disposal of a target protein recruitment of the ubiquitination-proteasome degradation machinery. Because of the chimeric nature of such molecules, their synthesis requires a key step of "assembling" whether in the lab or . Furthermore, targeted PROTACs often are hetero-trifunctional and require a second "assembling" step. Click chemistry has the unique advantages of tethering two or more molecular entities of choice under near physiological conditions and therefore has been applied to the development of PROTACs in various ways. This review provides a succinct summary of this field with a critical analysis of various factors that need to be considered for optimal results. Specifically, we examine issues including applications of click chemistry in assembly for improved delivery, conjugation with a targeting group for selectivity, rapid synthesis for linker optimization, and lysosomal degradation of extracellular and membrane-associated proteins. We also examine reaction kinetics issues whenever possible or warranted.

摘要

蛋白酶靶向嵌合体(PROTAC)是一种异双功能分子,旨在介导靶蛋白的清除,募集泛素化 - 蛋白酶体降解机制。由于此类分子的嵌合性质,无论在实验室还是其他地方,其合成都需要一个“组装”的关键步骤。此外,靶向PROTAC通常是异三功能的,需要第二个“组装”步骤。点击化学具有在接近生理条件下连接两个或更多选定分子实体的独特优势,因此已以各种方式应用于PROTAC的开发。本综述对该领域进行了简要总结,并对为获得最佳结果需要考虑的各种因素进行了批判性分析。具体而言,我们研究了包括点击化学在组装中用于改善递送、与靶向基团缀合以实现选择性、快速合成以优化连接子以及细胞外和膜相关蛋白的溶酶体降解等问题。只要有可能或有必要,我们还研究了反应动力学问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf61/10915971/073581f75955/d3cb00199g-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf61/10915971/b4baa6ca325b/d3cb00199g-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf61/10915971/d57cbc2395ab/d3cb00199g-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf61/10915971/073581f75955/d3cb00199g-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf61/10915971/b4baa6ca325b/d3cb00199g-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf61/10915971/d57cbc2395ab/d3cb00199g-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf61/10915971/073581f75955/d3cb00199g-f6.jpg

相似文献

1
Click chemistry in the development of PROTACs.点击化学在PROTACs研发中的应用
RSC Chem Biol. 2023 Dec 29;5(3):189-197. doi: 10.1039/d3cb00199g. eCollection 2024 Mar 6.
2
Epigenetic therapy meets targeted protein degradation: HDAC-PROTACs in cancer treatment.表观遗传疗法与靶向蛋白质降解相结合:癌症治疗中的组蛋白去乙酰化酶-蛋白酶体靶向嵌合体
Future Med Chem. 2025 Jul 16:1-13. doi: 10.1080/17568919.2025.2533113.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Synthesis and Application of BRD4-Targeting ByeTACs (Bypassing E-Ligase Targeting Chimeras).靶向BRD4的ByeTACs(绕过E-连接酶靶向嵌合体)的合成与应用
Curr Protoc. 2025 Aug;5(8):e70196. doi: 10.1002/cpz1.70196.
6
Proteolysis Targeting Chimera (PROTAC) as a promising novel therapeutic modality for the treatment of triple-negative breast cancer (TNBC).蛋白水解靶向嵌合体(PROTAC)作为一种有前途的新型治疗方法,用于治疗三阴性乳腺癌(TNBC)。
Drug Dev Res. 2023 Jun;84(4):629-653. doi: 10.1002/ddr.22055. Epub 2023 Apr 5.
7
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
8
Short-Term Memory Impairment短期记忆障碍
9
Electrophoresis电泳
10
PROTAC-Based Antivirals for Respiratory Viruses: A Novel Approach for Targeted Therapy and Vaccine Development.基于PROTAC的呼吸道病毒抗病毒药物:靶向治疗和疫苗开发的新方法
Microorganisms. 2025 Jul 2;13(7):1557. doi: 10.3390/microorganisms13071557.

引用本文的文献

1
In-cell proximity target validation methods for heterobifunctional molecules with CRBN- or VHL-binder using AirID.使用AirID对具有CRBN或VHL结合剂的异双功能分子进行细胞内邻近靶点验证的方法
Commun Biol. 2025 Aug 30;8(1):1323. doi: 10.1038/s42003-025-08761-x.
2
Synthesis, biological evaluation and clinical trials of Cereblon-based PROTACs.基于 Cereblon 的 PROTAC 的合成、生物学评价及临床试验
Commun Chem. 2025 Jul 29;8(1):218. doi: 10.1038/s42004-025-01598-9.
3
Methods to accelerate PROTAC drug discovery.加速PROTAC药物发现的方法。

本文引用的文献

1
Bioorthogonal PROTAC Prodrugs Enabled by On-Target Activation.基于靶标激活的生物正交 PROTAC 前药。
J Am Chem Soc. 2023 Jun 28;145(25):14155-14163. doi: 10.1021/jacs.3c05159. Epub 2023 Jun 16.
2
Recent Advances in Pro-PROTAC Development to Address On-Target Off-Tumor Toxicity.近期靶向 PROTAC 开发进展,解决靶标外肿瘤毒性问题。
J Med Chem. 2023 Jul 13;66(13):8428-8440. doi: 10.1021/acs.jmedchem.3c00302. Epub 2023 Jun 14.
3
Click chemistry and drug delivery: A bird's-eye view.点击化学与药物递送:鸟瞰
Biochem J. 2025 Jun 25;482(13):BCJ20243018. doi: 10.1042/BCJ20243018.
4
PROTAC Technology as a New Tool for Modern Pharmacotherapy.PROTAC技术作为现代药物治疗的新工具。
Molecules. 2025 May 11;30(10):2123. doi: 10.3390/molecules30102123.
5
Recommended Tool Compounds: Thienotriazolodiazepines-Derivatized Chemical Probes to Target BET Bromodomains.推荐的工具化合物:靶向BET溴结构域的噻吩并三唑二氮杂卓衍生化学探针。
ACS Pharmacol Transl Sci. 2025 Mar 14;8(4):978-1012. doi: 10.1021/acsptsci.4c00726. eCollection 2025 Apr 11.
6
Signature of click chemistry in advanced techniques for cancer therapeutics.点击化学在癌症治疗先进技术中的印记。
RSC Adv. 2025 Apr 4;15(14):10583-10601. doi: 10.1039/d5ra01196e.
7
Application of a bivalent "click" approach to target tyrosyl-DNA phosphodiesterase 1 (TDP1).一种用于靶向酪氨酰-DNA磷酸二酯酶1(TDP1)的双价“点击”方法的应用。
RSC Med Chem. 2025 Feb 21;16(5):1969-1985. doi: 10.1039/d4md00824c. eCollection 2025 May 22.
Acta Pharm Sin B. 2023 May;13(5):1990-2016. doi: 10.1016/j.apsb.2022.10.015. Epub 2022 Oct 22.
4
Discovery of intracellular self-assembly protein degraders driven by tumor-specific activatable bioorthogonal reaction.发现由肿瘤特异性激活型生物正交反应驱动的细胞内自组装蛋白降解剂。
Eur J Med Chem. 2023 Sep 5;257:115497. doi: 10.1016/j.ejmech.2023.115497. Epub 2023 May 16.
5
Discovery of novel protein degraders based on bioorthogonal reaction-driven intracellular self-assembly strategy.基于生物正交反应驱动的细胞内自组装策略发现新型蛋白质降解剂。
Bioorg Chem. 2023 Jun;135:106497. doi: 10.1016/j.bioorg.2023.106497. Epub 2023 Mar 27.
6
Ligation to Scavenging Strategy Enables On-Demand Termination of Targeted Protein Degradation.连接到清除策略可实现靶向蛋白质降解的按需终止。
J Am Chem Soc. 2023 Apr 5;145(13):7218-7229. doi: 10.1021/jacs.2c12809. Epub 2023 Mar 27.
7
Hypoxia deactivates epigenetic feedbacks via enzyme-derived clicking proteolysis-targeting chimeras.缺氧通过酶衍生的点击蛋白水解靶向嵌合体使表观遗传反馈失活。
Sci Adv. 2022 Dec 14;8(50):eabq2216. doi: 10.1126/sciadv.abq2216.
8
Bifunctional Compounds as Molecular Degraders for Integrin-Facilitated Targeted Protein Degradation.作为整合素介导的靶向蛋白质降解分子降解剂的双功能化合物。
J Am Chem Soc. 2022 Dec 7;144(48):21831-21836. doi: 10.1021/jacs.2c08367. Epub 2022 Nov 23.
9
Novel Design Strategies to Enhance the Efficiency of Proteolysis Targeting Chimeras.提高蛋白酶靶向嵌合体效率的新型设计策略。
ACS Pharmacol Transl Sci. 2022 Aug 22;5(9):710-723. doi: 10.1021/acsptsci.2c00089. eCollection 2022 Sep 9.
10
Copper in the tumor microenvironment and tumor metastasis.肿瘤微环境中的铜与肿瘤转移
J Clin Biochem Nutr. 2022 Jul;71(1):22-28. doi: 10.3164/jcbn.22-9. Epub 2022 May 13.